Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · IEX Real-Time Price · USD
-0.014 (-4.76%)
At close: Apr 22, 2024, 3:58 PM
+0.006 (2.14%)
After-hours: Apr 22, 2024, 7:08 PM EDT

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $6.61 million. The enterprise value is $5.99 million.

Market Cap 6.61M
Enterprise Value 5.99M

Important Dates

The next estimated earnings date is Friday, May 3, 2024, after market close.

Earnings Date May 3, 2024
Ex-Dividend Date n/a

Share Statistics

Mangoceuticals has 23.62 million shares outstanding. The number of shares has increased by 49.22% in one year.

Shares Outstanding 23.62M
Shares Change (YoY) +49.22%
Shares Change (QoQ) +1.19%
Owned by Insiders (%) 42.44%
Owned by Institutions (%) 0.37%
Float 13.60M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.04
Forward PS n/a
PB Ratio 8.54
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.18
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.17.

Current Ratio 3.88
Quick Ratio n/a
Debt / Equity 0.17
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -411.70% and return on invested capital (ROIC) is -1,020.43%.

Return on Equity (ROE) -411.70%
Return on Assets (ROA) -366.40%
Return on Capital (ROIC) -1,020.43%
Revenue Per Employee $243,831
Profits Per Employee -$3.07M
Employee Count 3
Asset Turnover 0.29
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.85% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -85.85%
50-Day Moving Average 0.23
200-Day Moving Average 0.65
Relative Strength Index (RSI) 58.99
Average Volume (30 Days) 945,074

Short Selling Information

The latest short interest is 692,082, so 2.93% of the outstanding shares have been sold short.

Short Interest 692,082
Short Previous Month 149,057
Short % of Shares Out 2.93%
Short % of Float 5.09%
Short Ratio (days to cover) 0.60

Income Statement

In the last 12 months, Mangoceuticals had revenue of $731,493 and -$9.21 million in losses. Loss per share was -$0.57.

Revenue 731,493
Gross Profit 431,501
Operating Income -9.22M
Pretax Income -9.21M
Net Income -9.21M
EBIT -9.21M
Loss Per Share -$0.57
Full Income Statement

Balance Sheet

The company has $755,948 in cash and $128,679 in debt, giving a net cash position of $627,269 or $0.03 per share.

Cash & Cash Equivalents 755,948
Total Debt 128,679
Net Cash 627,269
Net Cash Per Share $0.03
Equity / Book Value 774,754
Book Value Per Share 0.03
Working Capital 607,382
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.00 million and capital expenditures -$3,519, giving a free cash flow of -$7.00 million.

Operating Cash Flow -7.00M
Capital Expenditures -3,519
Free Cash Flow -7.00M
FCF Per Share -$0.43
Full Cash Flow Statement


Gross margin is 58.99%, with operating and profit margins of -1,260.28% and -1,259.40%.

Gross Margin 58.99%
Operating Margin -1,260.28%
Pretax Margin -1,259.40%
Profit Margin -1,259.40%
EBITDA Margin -1,256.00%
EBIT Margin -1,259.40%
FCF Margin -957.07%

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.22%
Shareholder Yield -49.22%
Earnings Yield -139.30%
FCF Yield -105.86%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Mangoceuticals has an Altman Z-Score of -28.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -28.13
Piotroski F-Score 5